(Q36242965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

3

Bolesław Rutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

Wojciech Larczynski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

25 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

Kidney and Blood Pressure Research

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

230-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin II type 2 receptor mediates programmed cell death

6 January 2020

cites work

1 reference

Aldosterone in the development and progression of renal injury

21 January 2018

1 reference

ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells

21 January 2018

1 reference

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

21 January 2018

1 reference

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

21 January 2018

1 reference

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade

21 January 2018

1 reference

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

21 January 2018

1 reference

Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy

21 January 2018

1 reference

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis

21 January 2018

1 reference

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

Reversal of Glomerulosclerosis after High-Dose Enalapril Treatment in Subtotally Nephrectomized Rats

21 January 2018

1 reference

Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy

21 January 2018

1 reference

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

21 January 2018

1 reference

Angiotensin II Induces alpha3(IV) Collagen Expression in Cultured Murine Proximal Tubular Cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000087842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16127280%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference